01 /What it is
EGF (Epidermal Growth Factor) is a 53 amino acid polypeptide first described by Stanley Cohen, work that earned him the 1986 Nobel Prize in Physiology or Medicine. It binds the EGF receptor (EGFR) and triggers downstream signaling that drives cell proliferation and migration in research models.
02 /How it works
In research models, EGF binds EGFR on cell surfaces and activates the MAPK and PI3K signaling cascades that drive cell division and tissue repair responses. It is one of the most heavily studied growth factors in cell culture research and a reference compound across wound healing and dermal biology research.
03 /What researchers explore it for
Researchers have explored EGF in wound healing research, in cell proliferation research, and in dermal repair research.
04 /Safety and interactions
EGF is for laboratory research use only and is not for human consumption. Not medical advice. Not intended to diagnose, treat, cure, or prevent any disease.
05 /Research notes
Peptide family: growth factor polypeptides. Frequently compared with IGF-1 and MGF in proliferation research. EGF is available as a prescription topical (Heberprot-P) in several regulated markets, which is why the Apothify library lists it for encyclopedia coverage only.
